Unichem Laboratories Limited — Board Meeting, 04-08-2025: Outcome of Board Meeting

Unichem Lab's Board has approved the financial results for the quarter ended June 30, 2025. The company saw consolidated revenue from operations rise to ₹526.60 Cr this quarter, up from ₹483.34 Cr in the same period last year. However, Unichem reported a consolidated net loss of ₹10.47 Cr, compared to a profit of ₹2.07 Cr in Q1 FY25. A key corporate development includes Unichem Laboratories Ireland ceasing to be a subsidiary as of April 30, 2025. Investors should also note that prior year (Q1 FY25) figures have been restated to reflect the Bayshore USA transaction from the common control date.